高聚生在肺癌肝转移中的治疗作用(附62例分析)  

Treatment effect of using staphylococal enterotoxin C on lung cancer liver metastatic patients

作　　者：许申[1] 洪波[2] 陈宓[3] 

机构地区：[1]安徽省肺科医院,230031 [2]安徽合肥市第二人民医院,230011 [3]安徽合肥市第九人民医院,230001

出　　处：《临床肺科杂志》2008年第4期403-404,共2页Journal of Clinical Pulmonary Medicine

摘　　要：目的分折高聚生介入给药治疗肺癌肝转移的疗效。方法确诊的62例肺癌肝转移患者随机分高聚生介入治疗组及单纯化疗药介入治疗组,每月1次、共治疗3次,评价临床疗效,毒副反应,随访生活质量及生存时间。结果两组之间有效率差异有显著性。结论高聚生联合化疗治疗肺癌肝转移,能提高患者生存质量,降低化疗的毒副作用,提高有效率。Objective To evaluate the treatment effect of using staphylococal enterotoxin C （SEC） on lung cancer liver metastatic patients. Methods A total of confirmed 62 lung cancer liver metastatic patients were divided into two groups at random. The treatment group was given regular interventional therapy and the SEC group was given in additon the SEC. Each group was treated once each month. The clincial evaluation of the treatment effects were performed after three consecutive treatment times, and the measures of the evanation included clinical effects, toxin and side effects, life quality and survival time. Results The two groups were siguficant different in the measures. Conclusion The use of SEC can improve the patients＇ life quality and reduce the side effects of the chemotherapy.

关 键 词：高聚生 介入治疗 肺癌肝转移 

分 类 号：R734.2[医药卫生—肿瘤]